By July, this number increased to 2,736, reflecting growing awareness of Paragard IUD risks
Safety, tolerability, access, cost, and individual response all play important roles
the Judicial Panel on Multidistrict Litigation added Saxenda to MDL 3094 in December 2024, expanding the scope to include this earlier-generation GLP-1 medication The consolidation of these medications into a single MDL proceedings streamlines the litigation process while allowing each plaintiff to maintain their individual claim for damages
Unfair competition : that these practices diverted potential customers away from Lillys FDA-approved Zepbound and Mounjaro
5C, D, Supplementary Table 3)
Always consult a dermatologist experienced in intimate area treatments before considering professional procedures